A detailed history of Icon Wealth Advisors, LLC transactions in Repligen Corp stock. As of the latest transaction made, Icon Wealth Advisors, LLC holds 32,571 shares of RGEN stock, worth $5.15 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
32,571
Previous 1,493 2081.58%
Holding current value
$5.15 Million
Previous $188,000 2478.19%
% of portfolio
0.14%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.79 - $167.35 $3.78 Million - $5.28 Million
-31,527 Reduced 96.79%
1,044 $155,000
Q3 2024

Nov 12, 2024

BUY
$119.79 - $167.35 $3.72 Million - $5.2 Million
31,078 Added 2081.58%
32,571 $4.85 Million
Q2 2024

Aug 14, 2024

SELL
$120.0 - $182.95 $28,920 - $44,090
-241 Reduced 13.9%
1,493 $188,000
Q1 2024

May 15, 2024

SELL
$170.78 - $208.42 $24,421 - $29,804
-143 Reduced 7.62%
1,734 $318,000
Q4 2023

Feb 14, 2024

BUY
$114.17 - $185.35 $214,297 - $347,901
1,877 New
1,877 $337,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.78B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Icon Wealth Advisors, LLC Portfolio

Follow Icon Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Icon Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Icon Wealth Advisors, LLC with notifications on news.